Market Outlook
The Microfluidics Market was valued at USD 39.65 Billion in 2025 and is projected to grow to USD 100.30 Billion by 2033, with a compound annual growth rate (CAGR) of 12.3% from 2027 to 2033. The microfluidics market focuses on technologies that manipulate small volumes of fluid through tiny channels, allowing for precise and efficient fluid control. It has a wide range of applications in healthcare, life sciences, environmental monitoring, and industrial processes. Key components of this market include microfluidic chips, valves, pumps, sensors, and integrated lab-on-a-chip systems. The market is experiencing growth due to its versatility and the ability to reduce costs while improving efficiency across various sectors.
Market drivers include the increasing demand for point-of-care testing (POCT), which provides rapid, on-site diagnostics. Advances in lab-on-a-chip technologies enable the integration of multiple laboratory functions, streamlining complex processes. The rising prevalence of chronic diseases such as cancer and diabetes has intensified the need for accurate diagnostic tools, leading to greater adoption in healthcare. Additionally, microfluidics plays a critical role in drug discovery and personalized medicine through applications like high-throughput screening and organ-on-chip studies, further accelerating growth.
Emerging opportunities involve integrating microfluidics with AI and big data, which enhances diagnostics and analytics. The market is also expanding into wearable health devices, catering to the growing demand for continuous health monitoring. Moreover, increased funding and research and development investments encourage innovation, while the use of sustainable microfluidic materials aligns with global environmental goals. Emerging economies present untapped potential for affordable and accessible solutions, driving future growth.
Key Insights
North America accounted for the largest share of the Microfluidics market at 48.30% in 2025. North America leads the global microfluidics market, thanks to its advanced healthcare infrastructure, substantial investments in research and development, and the presence of major industry players. The United States, in particular, stands out in this region, bolstered by strong government funding, extensive academic research, and collaboration between biotechnology and pharmaceutical companies.
A growing focus on point-of-care (POC) testing and diagnostics for chronic and infectious diseases further drives market growth. Additionally, the high adoption of advanced diagnostic technologies and microfluidic devices for drug delivery and genomics research strengthens this leadership position. North America also benefits from a well-established regulatory framework that supports innovation and commercialization. Furthermore, the region boasts a skilled workforce and state-of-the-art facilities for manufacturing and research.
In terms of Technology, the Lab-on-a-Chip (LoC) accounted for a major share of 30.2%in 2025. The Lab-on-a-Chip (LoC) segment dominates the global microfluidics market due to its versatility, miniaturization, and integration of multiple laboratory functions on a single chip. LoC technology is widely used in point-of-care diagnostics, offering rapid, portable, and accurate solutions for healthcare settings. Its applications span molecular diagnostics, drug discovery, and environmental testing, driving demand across industries. Advancements in materials and manufacturing have improved affordability and efficiency, further boosting adoption. With the growing need for personalized medicine and quick diagnostic tools, Lab-on-a-Chip remains a critical driver of innovation and market growth within the microfluidics industry.
Market Dynamics
The increasing preference for rapid, accurate, and portable diagnostic solutions has driven the adoption of microfluidics in POCT applications.
The growing demand for quick, accurate, and portable diagnostic solutions has significantly increased the adoption of microfluidics in point-of-care testing (POCT). POCT enables immediate diagnostic results close to the patient, facilitating faster clinical decision-making and improved healthcare outcomes. This demand arises from the need to address time-sensitive conditions such as infectious diseases, cardiovascular events, and chronic illnesses like diabetes. Traditional laboratory-based testing often involves delays due to sample transportation, preparation, and processing, making rapid diagnostic alternatives essential.
Microfluidic devices, also known as lab-on-a-chip systems, have transformed POCT by integrating multiple laboratory functions into compact, portable formats. These devices require minimal sample volumes and can deliver highly accurate results within minutes, making them ideal for use in remote areas, emergency situations, or resource-limited settings. Additionally, microfluidics allows for the simultaneous detection of multiple biomarkers, enhancing diagnostic efficiency and expanding their application range.
The COVID-19 pandemic underscored the importance of these technologies, as microfluidics-powered POCT kits played a crucial role in mass testing efforts. Moreover, advancements in materials science, miniaturization, and automation have made these devices more affordable and user-friendly, promoting widespread adoption. As healthcare systems worldwide shift toward decentralized and patient-centered care models, microfluidics is likely to remain a key component of POCT innovation.
Precision engineering and the integration of different materials and technologies increase manufacturing complexity.
The manufacturing of microfluidic devices involves precision engineering to create intricate microscale channels, valves, and structures that enable the manipulation of tiny fluid volumes. Achieving this level of detail requires advanced fabrication techniques such as photolithography, injection molding, and 3D printing, which demand high levels of accuracy and expertise.
Microfluidic devices often integrate multiple materials like polymers, glass, and silicon, each chosen for specific properties such as biocompatibility, transparency, or chemical resistance. Combining these materials into a single device without compromising functionality or durability is challenging, requiring meticulous bonding and alignment processes.
Also, the integration of technologies such as sensors, electronics, and actuators into these compact systems adds another layer of complexity. Ensuring compatibility between components, maintaining device stability, and preventing issues like leakage or biofouling are significant hurdles. These challenges collectively make the manufacturing process costly and technically demanding, limiting scalability.
| Key Pointers | Values |
| Category | Healthcare |
| Pages | 445 |
| Table Count | 355 |
| Chart Count | 240 |
| Companies Analyzed | 20 |
| Report Focus | Global |
| Largest Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| CAGR % (2027-2033) | 12.3% |
| Forecast Year | 2027-2033 |
| Historical Year | 2015-2024 |
| Market Size in 2025 | USD 39.65 Billion |
| Market Size in 2033 | USD 100.30 Billion |
| Countries Covered | U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Turkey, Israel, China, Japan, India, South Korea, Australia, SEA, Brazil, Chile, Argentina, Saudi Arabia, UAE, Qatar, South Africa, Rest of World |
| Key Driver & Challenges |
Advancements in healthcare diagnostics, rising demand for point-of-care testing, and increasing applications in pharmaceuticals and biotechnology. High device development costs, complex regulatory frameworks, and technical challenges in scaling up production and ensuring device reliability. |
| Segments Covered | By Technology, By Application, By Material, By End User |
Segmental Analysis
Based on Technology, Microfluidics market is segmented into Lab-on-a-Chip (LoC), Microarrays, Microfluidic Chips, Digital Microfluidics, Centrifugal Microfluidics, Others.
The Lab-on-a-Chip (LoC) segment leads the global microfluidics market due to significant advancements in the miniaturization and automation of laboratory processes. LoC integrates multiple laboratory functions onto a single chip, making it ideal for applications in diagnostics, research, and point-of-care testing. This technology enables rapid, cost-effective, and high-throughput analysis with minimal sample volumes, making it particularly attractive in medical diagnostics, especially for disease detection, genetic testing, and personalized medicine.
LoC systems are increasingly popular because they allow for real-time monitoring and quicker results, which are critical in clinical settings and pharmaceutical research. The ability to combine various processes such as mixing, separation, and analysis onto a single platform enhances efficiency and reduces the need for bulky and expensive laboratory equipment. Furthermore, LoC can work with both biological and chemical samples, making it versatile across different sectors.
The growing demand for portable and point-of-care devices, combined with advancements in material science and microfabrication techniques, has accelerated the adoption of Lab-on-a-Chip technologies. Additionally, integrating LoC in personalized medicine, where patient-specific data is processed and analyzed, is expected to further boost its market dominance. Thus, its widespread applications and versatility position LoC as the leading technology in the microfluidics market.
| Segments | Values |
| By Application |
|
| By Material |
|
Regional Landscape
In the context of regional analysis, the Microfluidics market includes North America, Europe, Asia Pacific, South America, and the Middle East and Africa.
The market size of the North America was valued at USD 19.15 Billion in 2025 and is expected to reach USD 48.44 Billion by 2033, with a CAGR of 48.30% during the forecast period. North America is set to lead the Global Microfluidics Market, with the United States playing a pivotal role. Several factors contribute to this dominance. The region has a strong healthcare infrastructure and a high demand for innovative diagnostic solutions, driven by a rising prevalence of chronic diseases such as diabetes and cardiovascular disorders. Microfluidics technologies are particularly valuable for enabling point-of-care testing and providing rapid diagnostic results, which are essential in modern healthcare.
Furthermore, significant government funding for clinical trials, research, and medical innovations is fueling the region's market growth. U.S. universities and research institutions are at the forefront of advancing microfluidic technologies, supported by federal funding for drug discovery and biotechnology research. Additionally, North America is home to many leading microfluidics companies that continue to push innovation and product development in the field. Collectively, these factors establish North America as a strong leader in the microfluidics market, positioning the region for ongoing growth and innovation in healthcare and diagnostics.
Competitive Landscape
Some of the major companies operating within the Microfluidics market are: Danaher Corporation, Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Bio-Rad Laboratories, Illumina, Inc., F. Hoffmann-La Roche, Fluidigm Corporation, Qiagen, Abbott Laboratories, Biomerieux, Dolomite Microfluidics and Others.
Table of Contents
1. Global Microfluidics Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Microfluidics Market Scope and Market Estimation
1.2.1. Global Microfluidics Overall Market Size (US$ Billion), Market CAGR (%), Market forecast (2027 - 2033)
1.2.2. Global Microfluidics Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033
1.3. Market Segmentation
1.3.1. Technology of Global Microfluidics Market
1.3.2. Application of Global Microfluidics Market
1.3.3. Material of Global Microfluidics Market
1.3.4. End User of Global Microfluidics Market
1.3.5. Region of Global Microfluidics Market
2. Executive Summary
2.1. Demand Side Trends
2.2. Key Market Trends
2.3. Market Demand (US$ Billion) Analysis 2019 – 2025 and Forecast, 2027 – 2033
2.4. Demand and Opportunity Assessment
2.5. Market Dynamics
2.5.1. Drivers
2.5.2. Limitations
2.5.3. Opportunities
2.5.4. Impact Analysis of Drivers and Restraints
2.6. Cost Tear Down Analysis
2.7. Key Developments
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Buyers
2.8.3. Threat of Substitutes
2.8.4. Threat of New Entrants
2.8.5. Competitive Rivalry
2.9. PEST Analysis
2.9.1. Political Factors
2.9.2. Economic Factors
2.9.3. Social Factors
2.9.4. Technological Factors
3. Global Microfluidics Market Estimates & Historical Trend Analysis (2019 - 2023)
4. Global Microfluidics Market Estimates & Forecast Trend Analysis, by Technology
4.1. Global Microfluidics Market Revenue (US$ Billion) Estimates and Forecasts, Technology, 2019 - 2033
4.1.1. Lab-on-a-Chip (LoC)
4.1.2. Microarrays
4.1.3. Microfluidic Chips
4.1.4. Digital Microfluidics
4.1.5. Centrifugal Microfluidics
4.1.6. Others
5. Global Microfluidics Market Estimates & Forecast Trend Analysis, by Application
5.1. Global Microfluidics Market Revenue (US$ Billion) Estimates and Forecasts, Application, 2019 - 2033
5.1.1. In Vitro Diagnostics (IVD)
5.1.2. Pharmaceuticals and Life Sciences Research
5.1.3. Medical Devices
5.1.4. Environmental Monitoring
5.1.5. Others
6. Global Microfluidics Market Estimates & Forecast Trend Analysis, by Material
6.1. Global Microfluidics Market Revenue (US$ Billion) Estimates and Forecasts, Material, 2019 - 2033
6.1.1. Polymer-based Microfluidics
6.1.2. Glass-based Microfluidics
6.1.3. Silicon-based Microfluidics
6.1.4. Paper-based Microfluidics
6.1.5. Other Materials
7. Global Microfluidics Market Estimates & Forecast Trend Analysis, by End User
7.1. Global Microfluidics Market Revenue (US$ Billion) Estimates and Forecasts, End User, 2019 - 2033
7.1.1. Diagnostic Laboratories and Hospitals
7.1.2. Academic and Research Institutes
7.1.3. Pharmaceutical and Biotechnology Companies
7.1.4. Contract Research Organizations (CROs)
7.1.5. Others
8. Global Microfluidics Market Estimates & Forecast Trend Analysis, by Region
8.1. Global Microfluidics Market Revenue (US$ Billion) Estimates and Forecasts, by Region, 2019 - 2033
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Microfluidics Market: Estimates & Forecast Trend Analysis
9.1. North America Microfluidics Market Assessments & Key Findings
9.1.1. North America Microfluidics Market Introduction
9.1.2. North America Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
9.1.2.1. By Technology
9.1.2.2. By Application
9.1.2.3. By Material
9.1.2.4. By End User
9.1.2.5. By Country
9.1.2.5.1. The U.S.
9.1.2.5.1.1. By Technology
9.1.2.5.1.2. By Application
9.1.2.5.1.3. By Material
9.1.2.5.1.4. By End User
9.1.2.5.1.5. Top Companies Market Share in the U.S., 2019-2023
9.1.2.5.2. Canada
9.1.2.5.2.1. By Technology
9.1.2.5.2.2. By Application
9.1.2.5.2.3. By Material
9.1.2.5.2.4. By End User
9.1.2.5.2.5. Top Companies Market Share in Canada, 2019-2023
9.1.2.5.3. Mexico
9.1.2.5.3.1. By Technology
9.1.2.5.3.2. By Application
9.1.2.5.3.3. By Material
9.1.2.5.3.4. By End User
9.1.2.5.3.5. Top Companies Market Share in Mexico., 2019-2023
10. Western Europe Microfluidics Market: Estimates & Forecast Trend Analysis
10.1. Western Europe Microfluidics Market Assessments & Key Findings
10.1.1. Western Europe Microfluidics Market Introduction
10.1.2. Western Europe Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
10.1.2.1. By Technology
10.1.2.2. By Application
10.1.2.3. By Material
10.1.2.4. By End User
10.1.2.5. By Country
10.1.2.5.1. Germany
10.1.2.5.1.1. By Technology
10.1.2.5.1.2. By Application
10.1.2.5.1.3. By Material
10.1.2.5.1.4. By End User
10.1.2.5.1.5. Top Companies Market Share in Germany, 2019-2023
10.1.2.5.2. Italy
10.1.2.5.2.1. By Technology
10.1.2.5.2.2. By Application
10.1.2.5.2.3. By Material
10.1.2.5.2.4. By End User
10.1.2.5.2.5. Top Companies Market Share in Italy, 2019-2023
10.1.2.5.3. U.K.
10.1.2.5.3.1. By Technology
10.1.2.5.3.2. By Application
10.1.2.5.3.3. By Material
10.1.2.5.3.4. By End User
10.1.2.5.3.5. Top Companies Market Share in U.K, 2019-2023
10.1.2.5.4. France
10.1.2.5.4.1. By Technology
10.1.2.5.4.2. By Application
10.1.2.5.4.3. By Material
10.1.2.5.4.4. By End User
10.1.2.5.4.5. Top Companies Market Share in France, 2019-2023
10.1.2.5.5. Spain
10.1.2.5.5.1. By Technology
10.1.2.5.5.2. By Application
10.1.2.5.5.3. By Material
10.1.2.5.5.4. By End User
10.1.2.5.5.5. Top Companies Market Share in Spain, 2019-2023
10.1.2.5.6. Benelux
10.1.2.5.6.1. By Technology
10.1.2.5.6.2. By Application
10.1.2.5.6.3. By Material
10.1.2.5.6.4. By End User
10.1.2.5.6.5. Top Companies Market Share in Benelux, 2019-2023
10.1.2.5.7. Nordics
10.1.2.5.7.1. By Technology
10.1.2.5.7.2. By Application
10.1.2.5.7.3. By Material
10.1.2.5.7.4. By End User
10.1.2.5.7.5. Top Companies Market Share in Nordics, 2019-2023
10.1.2.5.8. Rest of W. Europe
10.1.2.5.8.1. By Technology
10.1.2.5.8.2. By Application
10.1.2.5.8.3. By Material
10.1.2.5.8.4. By End User
10.1.2.5.8.5. Top Companies Market Share in Rest of Western Europe, 2019-2023
11. Eastern Europe Microfluidics Market: Estimates & Forecast Trend Analysis
11.1. Eastern Europe Microfluidics Market Assessments & Key Findings
11.1.1. Eastern Europe Microfluidics Market Introduction
11.1.2. Eastern Europe Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
11.1.2.1. By Technology
11.1.2.2. By Application
11.1.2.3. By Material
11.1.2.4. By End User
11.1.2.5. By Country
11.1.2.5.1. Russia
11.1.2.5.1.1. By Technology
11.1.2.5.1.2. By Application
11.1.2.5.1.3. By Material
11.1.2.5.1.4. By End User
11.1.2.5.1.5. Top Companies Market Share in Russia, 2019-2023
11.1.2.5.2. Hungary
11.1.2.5.2.1. By Technology
11.1.2.5.2.2. By Application
11.1.2.5.2.3. By Material
11.1.2.5.2.4. By End User
11.1.2.5.2.5. Top Companies Market Share in Hungary, 2019-2023
11.1.2.5.3. Poland
11.1.2.5.3.1. By Technology
11.1.2.5.3.2. By Application
11.1.2.5.3.3. By Material
11.1.2.5.3.4. By End User
11.1.2.5.3.5. Top Companies Market Share in Poland, 2019-2023
11.1.2.5.4. Balkan & Baltics
11.1.2.5.4.1. By Technology
11.1.2.5.4.2. By Application
11.1.2.5.4.3. By Material
11.1.2.5.4.4. By End User
11.1.2.5.4.5. Top Companies Market Share in Balkan and Baltics, 2019-2023
11.1.2.5.5. Rest of E. Europe
11.1.2.5.5.1. By Technology
11.1.2.5.5.2. By Application
11.1.2.5.5.3. By Material
11.1.2.5.5.4. By End User
11.1.2.5.5.5. Top Companies Market Share in Eastern Europe, 2019-2023
12. Asia Pacific Microfluidics Market: Estimates & Forecast Trend Analysis
12.1. Asia Pacific Market Assessments & Key Findings
12.1.1. Asia Pacific Microfluidics Market Introduction
12.1.2. Asia Pacific Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
12.1.2.1. By Technology
12.1.2.2. By Application
12.1.2.3. By Material
12.1.2.4. By End User
12.1.2.5. By Country
12.1.2.5.1. China
12.1.2.5.1.1. By Technology
12.1.2.5.1.2. By Application
12.1.2.5.1.3. By Material
12.1.2.5.1.4. By End User
12.1.2.5.1.5. Top Companies Market Share in China, 2019-2023
12.1.2.5.2. Japan
12.1.2.5.2.1. By Technology
12.1.2.5.2.2. By Application
12.1.2.5.2.3. By Material
12.1.2.5.2.4. By End User
12.1.2.5.2.5. Top Companies Market Share in Japan, 2019-2023
12.1.2.5.3. India
12.1.2.5.3.1. By Technology
12.1.2.5.3.2. By Application
12.1.2.5.3.3. By Material
12.1.2.5.3.4. By End User
12.1.2.5.3.5. Top Companies Market Share in India, 2019-2023
12.1.2.5.4. Australia & New Zealand
12.1.2.5.4.1. By Technology
12.1.2.5.4.2. By Application
12.1.2.5.4.3. By Material
12.1.2.5.4.4. By End User
12.1.2.5.4.5. Top Companies Market Share in Australia and New Zealand, 2019-2023
12.1.2.5.5. South Korea
12.1.2.5.5.1. By Technology
12.1.2.5.5.2. By Application
12.1.2.5.5.3. By Material
12.1.2.5.5.4. By End User
12.1.2.5.5.5. Top Companies Market Share in South Korea, 2019-2023
12.1.2.5.6. ASEAN
12.1.2.5.6.1. By Technology
12.1.2.5.6.2. By Application
12.1.2.5.6.3. By Material
12.1.2.5.6.4. By End User
12.1.2.5.6.5. Top Companies Market Share in ASEAN, 2019-2023
12.1.2.5.7. Rest of Asia Pacific
12.1.2.5.7.1. By Technology
12.1.2.5.7.2. By Application
12.1.2.5.7.3. By Material
12.1.2.5.7.4. By End User
12.1.2.5.7.5. Top Companies Market Share in Rest of Asia Pacific 2019-2023
13. Middle East & Africa Microfluidics Market: Estimates & Forecast Trend Analysis
13.1. Middle East & Africa Market Assessments & Key Findings
13.1.1. Middle East & Africa Microfluidics Market Introduction
13.1.2. Middle East & Africa Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
13.1.2.1. By Technology
13.1.2.2. By Application
13.1.2.3. By Material
13.1.2.4. By End User
13.1.2.5. By Country
13.1.2.5.1. UAE
13.1.2.5.1.1. By Technology
13.1.2.5.1.2. By Application
13.1.2.5.1.3. By Material
13.1.2.5.1.4. By End User
13.1.2.5.1.5. Top Companies Market Share in UAE, 2019-2023
13.1.2.5.2. Saudi Arabia
13.1.2.5.2.1. By Technology
13.1.2.5.2.2. By Application
13.1.2.5.2.3. By Material
13.1.2.5.2.4. By End User
13.1.2.5.2.5. Top Companies Market Share in Saudi Arabia, 2019-2023
13.1.2.5.3. Turkey
13.1.2.5.3.1. By Technology
13.1.2.5.3.2. By Application
13.1.2.5.3.3. By Material
13.1.2.5.3.4. By End User
13.1.2.5.3.5. Top Companies Market Share in Turkey, 2019-2023
13.1.2.5.4. South Africa
13.1.2.5.4.1. By Technology
13.1.2.5.4.2. By Application
13.1.2.5.4.3. By Material
13.1.2.5.4.4. By End User
13.1.2.5.4.5. Top Companies Market Share in South Africa, 2019-2023
13.1.2.5.5. Rest of MEA
13.1.2.5.5.1. By Technology
13.1.2.5.5.2. By Application
13.1.2.5.5.3. By Material
13.1.2.5.5.4. By End User
13.1.2.5.5.5. Top Companies Market Share in Rest of MEA, 2019-2023
14. Latin America Microfluidics Market: Estimates & Forecast Trend Analysis
14.1. Latin America Market Assessments & Key Findings
14.1.1. Latin America Microfluidics Market Introduction
14.1.2. Latin America Microfluidics Market Size Estimates and Forecast (US$ Billion) (2019 - 2033)
14.1.2.1. By Technology
14.1.2.2. By Application
14.1.2.3. By Material
14.1.2.4. By End User
14.1.2.5. By Country
14.1.2.5.1. Brazil
14.1.2.5.1.1. By Technology
14.1.2.5.1.2. By Application
14.1.2.5.1.3. By Material
14.1.2.5.1.4. By End User
14.1.2.5.1.5. Top Companies Market Share in Brazil, 2019-2023
14.1.2.5.2. Argentina
14.1.2.5.2.1. By Technology
14.1.2.5.2.2. By Application
14.1.2.5.2.3. By Material
14.1.2.5.2.4. By End User
14.1.2.5.2.5. Top Companies Market Share in Argentina, 2019-2023
14.1.2.5.3. Colombia
14.1.2.5.3.1. By Technology
14.1.2.5.3.2. By Application
14.1.2.5.3.3. By Material
14.1.2.5.3.4. By End User
14.1.2.5.3.5. Top Companies Market Share in Colombia, 2019-2023
14.1.2.5.4. Rest of LATAM
14.1.2.5.4.1. By Technology
14.1.2.5.4.2. By Application
14.1.2.5.4.3. By Material
14.1.2.5.4.4. By End User
14.1.2.5.4.5. Top Companies Market Share in Rest of LATAM, 2019-2023
15. Country Wise Microfluidics Market: Introduction
16. Competition Landscape
16.1. Global Microfluidics Market Product Mapping
16.2. Global Microfluidics Market Concentration Analysis, by Leading Players / Innovators / Emerging Players / New Entrants
16.3. Global Microfluidics Market Tier Structure Analysis
16.4. Global Microfluidics Market Concentration & Company Market Shares (%) Analysis, 2023
17. Company Profiles
17.1. Danaher Corporation
17.1.1. Company Overview & Key Stats
17.1.2. Revenue (USD Million), Sales (Units), and Gross Margin & Market Share, 2019-2023
17.1.3. Product Portfolio & Pricing Analysis
17.1.4. SWOT Analysis
17.1.5. Business Strategy & Recent Developments
* Similar details would be provided for all the players mentioned below
17.2. Thermo Fisher Scientific
17.3. PerkinElmer
17.4. Agilent Technologies
17.5. Bio-Rad Laboratories
17.6. Illumina, Inc.
17.7. F. Hoffmann-La Roche
17.8. Fluidigm Corporation
17.9. Qiagen
17.10. Abbott Laboratories
17.11. Biomerieux
17.12. Dolomite Microfluidics
17.13. Others
18. Research Methodology
18.1. External Transportations / Databases
18.2. Internal Proprietary Database
18.3. Primary Research
18.4. Secondary Research
18.5. Assumptions
18.6. Limitations
18.7. Report FAQs